EUVIMEDScopri EUVIMED
Open access · CC BY-NC-ND 4.0

Twelve years of assessing the quality of preimplantation genetic testing for monogenic disorders

Zandra C Deans iD, Anil Biricik, Martine De Rycke, Gary L Harton, Miroslav Hornak, Farrah Khawaja, Céline Moutou, Jan Traeger-Synodinos, Pamela Renwick

Prenatal Diagnosis · 2023-04 · 43 (4) · 506-515

DOI: 10.1002/pd.6263 ↗

At a glance

Journal article in Prenatal Diagnosis, published online on 2022-11-18. Written by Zandra C Deans and 8 co-authors. Institution: GenQA, Department of Laboratory Medicine, Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, UK. Major MEDLINE topics: Preimplantation Diagnosis. Cited 4 times so far (Crossref); 11 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: CPA UK (Ltd).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Objective

Genomics Quality Assessment has provided external quality assessments (EQAs) for preimplantation genetic testing (PGT) for 12 years for eight monogenic diseases to identify sub‐optimal PGT strategies, testing and reporting of results, which can be shared with the genomics community to aid optimised standards of PGT services for couples.

Method

The EQAs were provided in two stages to mimic end‐to‐end protocols. Stage 1 involved DNA feasibility testing of a couple undergoing PGT and affected proband. Participants were required to report genotyping results and outline their embryo testing strategy. Lymphoblasts were distributed for mock embryo testing for stage 2. Submitted clinical reports and haplotyping results were assessed against peer‐ratified criteria. Performance was monitored to identify poor performance.

Results

The most common testing methodology was short tandem repeat linkage analysis (59%); however, the adoption of single nucleotide polymorphism‐based platforms was observed and a move from blastomere to trophectoderm testing. There was a variation in testing strategies, assigning marker informativity and understanding test limitations, some clinically unsafe. Critical errors were reported for genotyping and interpretation.

Conclusion

EQA provides an overview of the standard of preimplantation genetic testing‐M clinical testing and identifies areas of improvement for accurate detection of high‐risk embryos.

Subjects

MeSH terms (MEDLINE)

Preimplantation DiagnosisPregnancyFemaleHumansGenetic TestingBlastocystAneuploidy

Authors and institutions

  • GenQA, Department of Laboratory Medicine, Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, UK.
  • Eurofins Genoma Laboratories, Rome, Italy.
  • Centre for Medical Genetics, Universitair Ziekenhuis Brussel, Brussels, Belgium.
  • BioSkryb Genomics, Durham, North Carolina, USA.
  • Laboratory for Medical and Reproductive Genetics, REPROMEDA Biology Park, Brno, Czechia, USA.
  • Laboratoire de Diagnostic préimplantatoire, Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, Strasbourg, France.

ORCID profiles: Zandra C Deans

Funding

  • CPA UK (Ltd)

Cite

APA

Deans, Z. C., Biricik, A., De Rycke, M., Harton, G. L., Hornak, M., Khawaja, F., Moutou, C., Traeger-Synodinos, J., & Renwick, P. (2023). Twelve years of assessing the quality of preimplantation genetic testing for monogenic disorders. Prenatal Diagnosis, 43(4), 506-515. https://doi.org/10.1002/pd.6263

Vancouver

Deans ZC, Biricik A, De Rycke M, Harton GL, Hornak M, Khawaja F, et al. Twelve years of assessing the quality of preimplantation genetic testing for monogenic disorders. Prenatal Diagnosis. 2023;43(4):506-515. doi:10.1002/pd.6263

BibTeX
@article{Deans2023,
  author = {Deans, Zandra C and Biricik, Anil and De Rycke, Martine and Harton, Gary L and Hornak, Miroslav and Khawaja, Farrah and Moutou, Céline and Traeger-Synodinos, Jan and Renwick, Pamela},
  title = {Twelve years of assessing the quality of preimplantation genetic testing for monogenic disorders},
  journal = {Prenatal Diagnosis},
  year = {2023},
  volume = {43},
  number = {4},
  pages = {506--515},
  doi = {10.1002/pd.6263}
}
Start for free →